“We noticed clinically that we were getting more and more people into our clinical services that had been started on GLP-1 agonists and had experienced new onset or worsening eating disorder symptoms” – MEAL Co-Director, Dr. Aaron Keshen, was interviewed by CNN about the impact of weight loss medications on eating disorders.

This article summarizes qualitative literature on nutritional considerations for gender-diverse people. We discuss the need for increased trans literacy among clinicians, the creation of safe spaces for gender-diverse people with eating disorders, and the importance of dual competencies in eating disorders treatment and gender-affirming care. Read it in Frontiers in Nutrition!

By examining administrative health data, we hope to gauge how often eating disorders appear in NB health records, the populations who access care for eating disorders, and the costs of seeking care. Hopefully, this information will inform efforts to build treatment capacity in NB!

Despite glucagon-like peptide-1 receptor agonists (GLP-1As; e.g., semaglutide) increasingly being the topic of clinical and public discourse, little is known about their potential impact on ED symptoms. Read more about it in our article in IJED!

Listen to the Jan. 2, 2024 edition of CBC Maritime Noon with Bob Murphy for a discussion about diet culture, body image, and New Year’s resolutions with Mollie Cronin of Art Brat Comics and our own Dr. Emilie Lacroix!

Work-Study Research Assistant

Undergraduate Student, University of New Brunswick